What Researchers Did
Researchers described the management of a critically ill patient with severe carbon monoxide poisoning, suspected COVID-19, who required emergency hyperbaric oxygen treatment during the pandemic.
What They Found
They found that strict infection control, contact precautions, modified hospital workflows, and teamwork were crucial for safely administering hyperbaric oxygen treatment (HBOT) to a COVID-19 suspect patient. They also noted that intubated patients posed less risk than non-intubated, coughing patients during HBOT, and aerosol-generating procedures should occur in negative pressure rooms.
What This Means for Canadian Patients
This study highlights the importance of stringent infection control measures and adapted protocols to ensure safe delivery of critical treatments like hyperbaric oxygen therapy for patients with co-existing conditions, such as suspected COVID-19. It suggests that Canadian patients requiring emergency hyperbaric oxygen treatment could benefit from these enhanced safety protocols, minimizing infection risks during their care.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
As a single case report, the findings of this study may not be generalizable to a broader patient population.